EPOTREND 10000 IU INJECTION

Epotrend 10000IU injection combines active ingredients like Recombinant human erythropoietin Alfa/ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The medicine treats anaemia that is caused by chronic kidney illness (CKD) as well as chemotherapy for cancer or HIV treatment using zidovudine. It also decreases the requirement for transfusions of red blood cells for patients at risk of losing blood as a result of surgery planned and other surgical procedures.
Epotrend 10000IU injections should not be administered to patients suffering from excessive hypertension or one of the components thereof, active thrombotic microangiopathy (TMA) and Pure red cell cancer (PRCA), and seizures that are not controlled, as well as lactation or pregnancy. Also, it should be used carefully in patients with a history of blood clots, heart disease, kidney disease,e, stroke liver disease, thalassemia, sickle cell a, anaemia (SCA), anaemia plastic disorder, leukaemia or leukaemia; not recommended use in children who are under the age of 18 when the benefits outweigh the risk. Older adults taking this medication must be monitored closely for adverse reactions. Before you begin the drug, it’s crucial to consult your physician about the potential risks and advantages of Epotrend 10000IU injection.